This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Emerick Provides Update On Proposed Acquisition Of Western European Properties

VANCOUVER, Nov. 6, 2012 /PRNewswire/ - Emerick Resources Corp. (TSX-V: ERC) is pleased to announce that it has signed a binding Share Purchase Agreement to acquire all of the outstanding shares of Medgold Resource Ltd. (" Medgold"), a private company incorporated in England and Wales focused on the exploration and development of precious and base metals in Western Europe.  ( See Emerick news release of May 8, 2012.)

To acquire Medgold, the Company will issue 32,287,500 shares in its capital stock to Medgold's shareholders in proportion to their respective shareholdings in Medgold.  Emerick's resulting issued capital will be 52,416,078 shares, of which Medgold's shareholders will own 61.6%.  All outstanding options in Emerick and Medgold will be cancelled.

Based on the terms of the transaction, Emerick has applied to the TSX Venture Exchange (the "Exchange") to have its listing graduated from the NEX board to Tier 2 of the Exchange as a resource issuer.  Upon completion of the transaction, Emerick will change its name to "Medgold Resources Corp.".

The Exchange has conditionally approved the transaction, subject to approval by Emerick's shareholders and final approval by the Exchange.  An Annual and Special Meeting of the Shareholders of Emerick will be held on Friday, November 30, 2012 at which approval to the transaction will be sought, and the Management Proxy Circular describing the transaction is available for viewing on

Haywood Securities Inc., subject to completion of satisfactory due diligence, has agreed to act as sponsor to Emerick in connection with the transaction.  An agreement to sponsor should not be construed as any assurance with respect to the merits of the transaction or the likelihood of completion.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs